You may have noticed that PQA has a new look! Our fresh and modernized logo and color scheme reflects our positive, forward-looking view of the vital role of medications in health care – and our role in bringing the industry together to improve quality.
Health outcomes can be influenced by many factors other than the health care services received, including patient-related factors such as existing clinical conditions and sociodemographic status (SDS), which refers to a variety of socioeconomic and demographic factors.
The 2023 PQA Annual Meeting is the perfect opportunity to connect and expand your networks among PQA members and non-members alike. The meeting will feature over 50 speakers you won’t want to miss.!
The 2023 PQA Annual Meeting is less than five weeks away, and we are excited to welcome you all to Nashville!
PQA has launched two opportunities for members to self-nominate to participate in two Technical Expert Panels (TEP).
PQA has launched two proof-of-concept pilots to implement four promising blood pressure and hemoglobin A1C pharmacy measure concepts in value-based payment arrangements (VBAs) between payers and pharmacies. .
PQA has launched a new scholarship program to help pharmacy and other health care professions students from diverse backgrounds attend the 2023 PQA Annual Meeting, May 10-12, in Nashville, Tenn.
PQA’s 2023 calendar is shaping up to be full of opportunities for members to engage in our work and advance the quality of medication use.
We are excited to announce that registration for the 2023 PQA Annual Meeting will open next week. This year’s meeting is May 10-12 in Nashville. Tenn. Be on the lookout for that registration link to reserve your spot at the top event for medication-focused quality improvement professionals.
PQA published the second edition of the PQA Social Determinants of Health Resource Guide this week. The expanded guide profiles 32 SDOH services, including 12 new services and updates to nine initiatives from the first edition.
This year, PQA convened its members and stakeholders to advance our work on pharmacy performance measures and oral anticancer medication (OAM) use quality. As we move into 2023, PQA will continue to drive innovative measures and quality strategies.
PQA members are currently voting on one measure up for endorsement and four measures for retirement.
PQA will host an all-member webinar on Thursday, December 1, from 1:00-2:00 p.m. ET, to discuss the measures up for endorsement and retirement consideration.
We are excited to host members next week at the 2022 PQA Leadership Summit. This year we will explore quality and value in medication use from patient, provider, purchaser, payer and industry perspectives.
PQA is launching a national initiative to prioritize research and measurement strategies to improve the quality of care for individuals using oral anticancer medications (OAM).
Collaboration is one of PQA's greatest attributes, and our measure development process is the embodiment of how our diverse member organizations reach consensus on evaluating medication use quality. The public comment period is an important part of our systematic and transparent consensus-based process.
PQA offers a variety of student and professional programs, including experiential rotations, internships and fellowships. Each is focused on providing healthcare quality experience to diverse individuals from diverse disciplines.
PQA has been busy this year advancing the quality of medication use through measure development and stewardship, education, research and convening. Thank you for your engagement and participation in our work that supports better medication use and high-quality care.
PQA has begun developing a health plan performance measure for chronic obstructive pulmonary disease (COPD). COPD is a high-burden and expensive condition, so ensuring effective, high-quality treatment is a priority for patients and those who care for them.
We are excited to announce that we will be open registration for the 2022 PQA Leadership Summit later this month. This year's summit will take place November 10-11 in Arlington, Va., and explore quality and value in medication use from patient, provider, purchaser, payer and industry perspectives.
